Polymorphisms in XPD (Asp312Asn and Lys751Gln) genes, sunburn, and arsenic-related skin lesions

被引：0
|
作者：
Mccarty, K.
Zhou, W.
Quamruzzaman, Q.
Rahman, M.
Mahiuddin, G.
Smith, T.
Louise, R.
Su, L.
Christiani, D.
机构：
[1] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth Sci, Boston, MA 02115 USA
[2] Dhaka Commun Hosp Trust, Dhaka, Bangladesh
[3] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA
来源：
EPIDEMIOLOGY | 2006年 / 17卷 / 06期
关键词：
D O I：
10.1097/00001648-200611001-00373
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：S149 / S149
页数：1
相关论文
共 50 条
  • [1] Polymorphisms in XPD (Asp312Asn and Lys751Gln) genes, sunburn and arsenic-related skin lesions
    McCarty, Kathleert M.
    Smith, Thomas J.
    Zhou, Wei
    Gonzalez, Ernesto
    Quamruzzaman, Quazzi
    Mahiuddin, Golam
    Ryan, Louise
    Su, Li
    Christiani, David C.
    CARCINOGENESIS, 2007, 28 (08) : 1697 - 1702
  • [2] XPD Lys751Gln and Asp312Asn polymorphisms and bladder cancer risk: a meta-analysis
    Li, Chunxiang
    Jiang, Zheng
    Liu, Xinghan
    MOLECULAR BIOLOGY REPORTS, 2010, 37 (01) : 301 - 309
  • [3] XPD Asp312Asn and Lys751Gln polymorphisms and breast cancer susceptibility: A meta-analysis
    Yan, Yulan
    Liang, Hongjie
    Light, Morning
    Li, Taijie
    Deng, Yan
    Li, Meng
    Li, Shan
    Qin, Xue
    TUMOR BIOLOGY, 2014, 35 (03) : 1907 - 1915
  • [4] XPD Lys751Gln and Asp312Asn polymorphisms and bladder cancer risk: a meta-analysis
    Chunxiang Li
    Zheng Jiang
    Xinghan Liu
    Molecular Biology Reports, 2010, 37 : 301 - 309
  • [5] Meta-analysis of two ERCC2 (XPD) polymorphisms, Asp312Asn and Lys751Gln, in breast cancer
    Noel Pabalan
    Ofelia Francisco-Pabalan
    Lillian Sung
    Hamdi Jarjanazi
    Hilmi Ozcelik
    Breast Cancer Research and Treatment, 2010, 124 : 531 - 541
  • [6] Association Between the Asp312Asn, Lys751Gln, and Arg156Arg Polymorphisms in XPD and the Risk of Prostate Cancer
    Fu, Weijin
    Xiao, Feifan
    Zhang, Ruoheng
    Li, Jiatong
    Zhao, Dong
    Lin, Xuandong
    Xu, Yanzhen
    Song, Xiaowei
    Xie, Zhibin
    Wen, Qiongxian
    Yang, Xiaoli
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2017, 16 (06) : 692 - 704
  • [7] Meta-analysis of two ERCC2 (XPD) polymorphisms, Asp312Asn and Lys751Gln, in breast cancer
    Pabalan, Noel
    Francisco-Pabalan, Ofelia
    Sung, Lillian
    Jarjanazi, Hamdi
    Ozcelik, Hilmi
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 124 (02) : 531 - 541
  • [8] XPD Lys751Gln and Asp312Asn Polymorphisms and Susceptibility to Skin Cancer: A Meta-Analysis of 17 Case-control Studies
    Zhu, Hai-Li
    Bao, Ji-Ming
    Lin, Pei-Xin
    Li, Wen-Xia
    Zou, Zhen-Ning
    Huang, Ye-En
    Chen, Qing
    Shen, Hong
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (16) : 6619 - 6625
  • [9] The XPD Asp312 Asn and LyS751Gln polymorphisms, corresponding haplotype, and pancreatic cancer risk
    Jiao, Li
    Hassan, Manal M.
    Bondy, Melissa L.
    Abbruzzese, James L.
    Evans, Douglas B.
    Li, Donghui
    CANCER LETTERS, 2007, 245 (1-2) : 61 - 68
  • [10] XPD Lys751Gln and Asp312Asn Polymorphisms and Gastric Cancer Susceptibility: A Meta-analysis of Case-control Studies
    Yin, Qing-Hua
    Liu, Chuan
    Hu, Jian-Bing
    Meng, Rong-Rong
    Li, Lian
    Wang, Ya-Jie
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (01) : 231 - 236
12345